These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18678823)

  • 1. Dehydroepiandrosterone for myotonic dystrophy type 1.
    Pénisson-Besnier I; Devillers M; Porcher R; Orlikowski D; Doppler V; Desnuelle C; Ferrer X; Bes MC; Bouhour F; Tranchant C; Lagrange E; Vershueren A; Uzenot D; Cintas P; Solé G; Hogrel JY; Laforêt P; Vial C; Vila AL; Sacconi S; Pouget J; Eymard B; Chevret S; Annane D
    Neurology; 2008 Aug; 71(6):407-12. PubMed ID: 18678823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
    Chang DM; Lan JL; Lin HY; Luo SF
    Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
    Puymirat J; Bouchard JP; Mathieu J
    Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
    Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
    Binder G; Weber S; Ehrismann M; Zaiser N; Meisner C; Ranke MB; Maier L; Wudy SA; Hartmann MF; Heinrich U; Bettendorf M; Doerr HG; Pfaeffle RW; Keller E;
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1182-90. PubMed ID: 19126625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3773-9. PubMed ID: 16849414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHEA in elderly women and DHEA or testosterone in elderly men.
    Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
    N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G; Burman P; Wirén L; Engström BE; Nilsson AG; Ottosson M; Jonsson B; Bengtsson BA; Karlsson FA
    J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.
    Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ; Ferrando SJ
    Am J Psychiatry; 2006 Jan; 163(1):59-66. PubMed ID: 16390890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study.
    Walter MC; Reilich P; Lochmüller H; Kohnen R; Schlotter B; Hautmann H; Dunkl E; Pongratz D; Müller-Felber W
    J Neurol; 2002 Dec; 249(12):1717-22. PubMed ID: 12529796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function.
    Dhatariya KK; Greenlund LJ; Bigelow ML; Thapa P; Oberg AL; Ford GC; Schimke JM; Nair KS
    Mayo Clin Proc; 2008 Nov; 83(11):1218-25. PubMed ID: 18990320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
    Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC
    Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido.
    Panjari M; Bell RJ; Jane F; Wolfe R; Adams J; Morrow C; Davis SR
    J Sex Med; 2009 Sep; 6(9):2579-90. PubMed ID: 19619146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids.
    Dayal M; Sammel MD; Zhao J; Hummel AC; Vandenbourne K; Barnhart KT
    J Womens Health (Larchmt); 2005 Jun; 14(5):391-400. PubMed ID: 15989411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
    Poretsky L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison MC; Haller I; Rabkin J
    Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D; Laughlin GA; Kritz-Silverstein D; Barrett-Connor E
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
    van Vollenhoven RF; Park JL; Genovese MC; West JP; McGuire JL
    Lupus; 1999; 8(3):181-7. PubMed ID: 10342710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial.
    Hartkamp A; Geenen R; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
    Ann Rheum Dis; 2008 Jan; 67(1):91-7. PubMed ID: 17545193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.